Clinical Trials
596 trialsNCT06311357 2024-12-27
Percent Weight Change in the Medical Supplement Group of Early Breast Cancer
Department of Medical Services Ministry of Public Health of Thailand
Phase NA Unknown
NCT06288854 2024-11-21
Efficacy of Olanzapine on Weight Gain in Advanced Gynecologic Cancer with Paclitaxel and Carboplatin: a Double Blind, Placebo-controlled Randomized Trial
Department of Medical Services Ministry of Public Health of Thailand
Phase NA Unknown
NCT06586697 2024-09-19
First-line Treatment for ES-SCLC with Chemotherapy Combined with PD-1/PD-L1 Inhibitor Sequential Thoracic Radiotherapy
Henan Cancer Hospital
Phase 2 Unknown
NCT06120595 2024-06-27
Intervention Study Based on Real-world Data to Improve Quality of Life After Breast Cancer Treatment, the REBECCA-2 Study
Helse Stavanger HF
Phase NA Unknown
NCT06406673 2024-05-09
A Phase II Clinical Study of Cadonilimab in Treatment-naïve or Relapsed Extensive Small Cell Lung Cancer
Henan Cancer Hospital
Phase 2 Unknown
NCT06132776 2024-04-26
The Mamma HiToP Study
Vienna Hospital Association
Phase NA Unknown
NCT06384950 2024-04-25
Evaluating the Role of ChatGPT in Educating Patients With Early-stage Hepatocellular Carcinoma
Taipei Veterans General Hospital, Taiwan
Phase NA Unknown
NCT06007001 2024-04-19
eCAN
Sciensano
Phase NA Unknown
NCT05084625 2024-04-17
PACED-digitized Support During Adjuvant Endocrine Therapy
Region Stockholm
Phase NA Unknown
NCT05925257 2024-04-17
Digital Health Intervention to Improve Health Care and Outcomes for Breast Cancer Patients
Coordinación de Investigación en Salud, Mexico
Phase 2 Unknown
NCT06365866 2024-04-15
Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer.
Taipei Veterans General Hospital, Taiwan
Phase NA Unknown
NCT06061445 2024-04-12
Radiotherapy Combined With TKI and Anti-PD-1 Antibody for Stage IIIA Hepatocellular Carcinoma
Fujian Cancer Hospital
Phase NA Unknown
NCT06262542 2024-04-12
Efficacy and Safety of Chinese Herb Medicine-Moxibustion Therapy on Chemotherapy-Induced Leukopenia
Taichung Armed Forces General Hospital
Phase NA Unknown
NCT06231680 2024-03-29
Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)
Henan Cancer Hospital
Phase 2 Unknown
NCT06334757 2024-03-28
Serplulimab Plus Bevacizumab and Chemotherapy for EGFR-mutant Metastatic NSCLC Patients After EGFR-TKI Treatment Failure
Henan Cancer Hospital
Phase 2 Unknown
NCT06335147 2024-03-28
PD1 Antibody Combined With mFOLFOX6 Neoadjuvant Therapy for Advanced Resectable Metastatic Colon Cancer
Henan Cancer Hospital
Phase NA Unknown
NCT03423199 2024-03-22
PATHWAY
National Cancer Center, Japan
Phase 3 Unknown
NCT05536154 2024-03-19
Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies
The Affiliated People's Hospital of Ningbo University
Phase NA Unknown
NCT06313775 2024-03-15
Comparison of Spinal Anesthesia and Spermatic Cord Block for Bilateral Orchiectomy
Sanpasitthiprasong Hospital
Phase NA Unknown
NCT05697913 2024-03-06
Efficacy of Response-adapted Treatment in Patients With Multiple Myeloma Candidates for Bone Marrow Transplantation
Hospital Galdakao-Usansolo
Phase NA Unknown
NCT06250166 2024-02-28
Feasibility, Acceptability, and Effectiveness of an Individualized Plant-based (iPLANT) Diet Plan in Colorectal Cancer: Mixed Method Embedded Design
National Cancer Institute, Malaysia
Phase NA Unknown
NCT06277011 2024-02-26
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research
Anhui Provincial Hospital
Phase EARLY_PHASE1 Unknown
NCT06262555 2024-02-16
Novel Light Delivery Method for Performing Transbronchial Photodynamic Therapy for Peripheral Lung Cancer
Taoyuan General Hospital
Phase NA Unknown
NCT06260150 2024-02-15
Application of IPC During Surgery to Prevent Venous Thrombosis in Gastrointestinal Surgery Patients.
Shandong Provincial Hospital
Phase NA Unknown
NCT05587192 2024-02-12
RPWPB
Anhui Provincial Hospital
Phase NA Unknown
NCT05189483 2024-02-07
Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma.
Henan Cancer Hospital
Phase 2 Unknown
NCT05598229 2024-02-07
Application of Douyin in Perioperative Period of Malignant Tumor Patients
Henan Cancer Hospital
Phase NA Unknown
NCT05598827 2024-02-07
Application of Douyin in Patients With Bone and Soft Tissue Malignant Tumors During Perichemotherapy
Henan Cancer Hospital
Phase NA Unknown
NCT05718778 2024-02-07
Piamprilizumab (AK105) Combined With Radiotherapy for Neoadjuvant Treatment of Soft Tissue Sarcoma
Henan Cancer Hospital
Phase NA Unknown
NCT06227325 2024-01-26
Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With HER2 Overexpression
Henan Cancer Hospital
Phase 2 Unknown
NCT06217224 2024-01-22
PBMT/MTX
Instituto Nacional de Cancer, Brazil
Phase NA Unknown
NCT06208033 2024-01-17
SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)
Fujian Cancer Hospital
Phase EARLY_PHASE1 Unknown
NCT06199024 2024-01-10
Cinnamon and COH in PCOS Women Underdoing IVF/ICSI Cycles
Royan Institute
Phase NA Unknown
NCT06197438 2024-01-09
Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric Cancer
Fujian Cancer Hospital
Phase 2 Unknown
NCT06095323 2023-12-20
Comparing Level 1 Compression Sleeves With Routine Care in Preventing Breast Cancer-related Arm Lymphedema
Henan Cancer Hospital
Phase NA Unknown
NCT06160362 2023-12-07
The Safety and Efficacy of Double-target CART-19 and 20 Cells in Non-Hodgkin's Lymphoma (NHL)
Henan Cancer Hospital
Phase NA Unknown
NCT05063760 2023-12-05
ExCell
Slovak Academy of Sciences
Phase NA Unknown
NCT04257175 2023-11-28
CAR-T CD19 for Acute Myelogenous Leukemia With t 8:21 and CD19 Expression
Sheba Medical Center
Phase 2/3 Unknown
NCT04989335 2023-11-28
Bisantrene Combination for Resistant AML
Sheba Medical Center
Phase 2 Unknown
NCT05088889 2023-11-28
Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer
Sheba Medical Center
Phase 1 Unknown
NCT04903561 2023-11-24
BELGSSAR
Sciensano
Phase NA Unknown
NCT05747157 2023-11-21
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10- 19) in the Treatment of r/r B-ALL Clinical Research
Anhui Provincial Hospital
Phase EARLY_PHASE1 Unknown
NCT06136910 2023-11-18
Oncorine (H101) Combined With Tislelizumab and Chemotherapy in Previously Untreated Advanced Non-small Cell Lung Cancer
Fujian Cancer Hospital
Phase 1/2 Unknown
NCT05839470 2023-11-15
Cadonilimab Plus FOLFOXIRI and Bevacizumab as First Line Therapy for Metastatic MSS Colorectal Cancer
Fujian Cancer Hospital
Phase 2 Unknown
NCT03750539 2023-11-14
Chemotherapy and Pelvic Hypofractionated Radiation Followed by Surgery Cervical Cancer
National Institute of Cancerología
Phase NA Unknown
NCT03899376 2023-11-14
ATGCRT
National Institute of Cancerología
Phase NA Unknown
NCT04070976 2023-11-14
Chemotherapy and Pelvic Hypofractionated Radiation Followed by Brachytherapy for Cervical Cancer
National Institute of Cancerología
Phase NA Unknown
NCT05490667 2023-10-30
Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumor
Henan Cancer Hospital
Phase NA Unknown
NCT06105658 2023-10-30
Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With AML
Anhui Provincial Hospital
Phase 2 Unknown
NCT05510089 2023-10-10
Etoposide+Cytarabine+PEG-rhG-CSF for Hematopoietic Stem Cell Mobilization in Patients With Hematological Malignancies
The Affiliated People's Hospital of Ningbo University
Phase NA Unknown